The frequent coexistence of multiple coagulation abnormalities (e.g., MTHFR mutations, protein S deficiency) in seven patients suggests a compounded thrombotic risk, necessitating long-term anticoagulation and close monitoring. The gene discussed is PROS1; the disease is hyperinsulinemic hypoglycemia, familial, 4.